AMRN (STOCKS)
Amarin Corp Plc
$14.000000
-0.060000 (-0.43%)
Prev close: $14.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Aaron D. Berg
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $297.29M
- Employees
- 275
- P/E (TTM)
- -10.83
- P/B (TTM)
- 0.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
2
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.04 | $-0.01 | +0.0502 | +492.16% |
|
Mar 2026 (Q1)
|
$-0.09 | $0.09 | -0.1767 | -203.81% |
|
Dec 2025 (Q4)
|
$0.01 | $0.00 | +0.0100 | +0.00% |
|
Sep 2025 (Q3)
|
$0.08 | $-0.58 | +0.6614 | +113.76% |
Financial Statements
| Revenues | $186.23M |
| Benefits Costs and Expenses | $211.79M |
| Cost Of Revenue | $108.10M |
| Costs And Expenses | $211.79M |
| Gross Profit | $78.14M |
| Operating Expenses | $118.91M |
| Selling, General, and Administrative Expenses | $83.06M |
| Research and Development | $19.02M |
| Other Operating Expenses | $16.83M |
| Operating Income/Loss | -$40.77M |
| Income/Loss From Continuing Operations After Tax | -$27.12M |
| Income/Loss From Continuing Operations Before Tax | -$25.56M |
| Income Tax Expense/Benefit | $1.57M |
| Net Income/Loss | -$27.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$27.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$27.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.07 |
| Diluted Earnings Per Share | -$0.07 |
| Basic Average Shares | 1,251,406,000 |
| Diluted Average Shares | 1,251,406,000 |
| Assets | $624.36M |
| Current Assets | $602.76M |
| Inventory | $164.07M |
| Other Current Assets | $438.69M |
| Noncurrent Assets | $21.61M |
| Liabilities | $180.75M |
| Current Liabilities | $164.20M |
| Accounts Payable | $18.80M |
| Other Current Liabilities | $145.40M |
| Noncurrent Liabilities | $16.55M |
| Equity | $443.62M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $443.62M |
| Liabilities And Equity | $624.36M |
| Net Cash Flow From Operating Activities | $15.57M |
| Net Cash Flow From Operating Activities, Continuing | $15.57M |
| Net Cash Flow From Investing Activities | -$17.81M |
| Net Cash Flow From Investing Activities, Continuing | -$17.81M |
| Net Cash Flow From Financing Activities | -$2.19M |
| Net Cash Flow From Financing Activities, Continuing | -$2.19M |
| Net Cash Flow | -$4.42M |
| Net Cash Flow, Continuing | -$4.42M |
| Comprehensive Income/Loss | -$27.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$27.12M |
| Other Comprehensive Income/Loss | $0.00 |